Indonesia, Kyrgyzstan, Philippines, Ukraine, Uzbekistan, and Viet Nam presented results of LIFT-TB operational research program at the Union Conference on
NEW YORK (November 13, 2023)—Indian pharmaceutical company Macleods has become the second manufacturer to launch pretomanid, a new medicine and
ISLAMABAD and PRETORIA (9 November 2023)—The Association for Social Development (ASD) has registered 206 participants with drug-resistant tuberculosis (DR-TB) in
“We are heartened to see that progress against tuberculosis (TB) has started to rebound after several years of increased numbers
The 2023 United Nations (UN) High-Level Meeting (HLM) on Tuberculosis (TB) saw world leaders come together to commit to increased
TB Alliance wholeheartedly supports the commitment made today at the United Nations High-Level Meeting on Tuberculosis (TB) to fight this
NEW YORK (September 15, 2023) — Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
NEW YORK (August 10, 2023)—Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license
NEW YORK (July 28, 2023)—TB Alliance applauds all efforts to expand access responsibly to lifesaving TB technologies. Stimulating market competition
